S1PR4 and asthma: In summary, we have demonstrated that a disturbance in sphingosine metabolism existed in asthma patients independent of different endotypes while the crucial sphingosine receptor S1PR4 was altered in patients and experimental mice, especially those with neutrophilic airway inflammation.